{"id":224910,"date":"2026-09-01T11:03:51","date_gmt":"2026-09-01T05:33:51","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=224910"},"modified":"2026-09-01T11:03:53","modified_gmt":"2026-09-01T05:33:53","slug":"emcure-pharmaceuticals-vs-nifty-50-share-price-performance","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/emcure-pharmaceuticals-vs-nifty-50-share-price-performance\/","title":{"rendered":"Emcure Pharmaceuticals vs Nifty 50: Returns Compared"},"content":{"rendered":"
<\/div>\n

Emcure Pharmaceuticals share price Rs 1,843.90 on NSE. Emcure Pharmaceuticals vs Nifty 50 over 1 year: +33.46% vs -2.41%. 52-week high Rs 2,048.00, low Rs 1,305.20.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Emcure Pharmaceuticals vs Nifty 50 shows Emcure Pharmaceuticals ahead of the benchmark on a one-year view, gaining +33.46% against the Nifty 50’s -2.41%. With only a short listing history, longer-term comparisons against the Nifty 50 are not yet meaningful for this stock. Investors comparing the two should also weigh Emcure Pharmaceuticals’s trading liquidity, valuation and sector context rather than relying on returns alone.<\/p>\n<\/div>\n

Emcure Pharmaceuticals vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Emcure Pharmaceuticals trades on the NSE under the symbol EMCURE, and its 1M return of -5.93% compares with the Nifty 50’s -1.44% over the same period.<\/p>\n

The Emcure Pharmaceuticals vs Nifty 50 comparison matters because Emcure Pharmaceuticals is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Emcure Pharmaceuticals share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, using NSE closing data.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n